Results 141 to 150 of about 15,701 (194)

Dual Empagliflozin and Sacubitril/Valsartan Therapy Improves Ex Vivo Cardiac Function in a Rat Model of Heart Failure. [PDF]

Biomedicines
Murić M, Srejović I, Ravić M, Joksimović Jović J, Sretenović J, Nikolić M, Lazarević N, Andjić M, Kočović A, Bolevich S, Jakovljević V, Novaković J.   +11 more
europepmc   +1 more source

Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection fraction: a systematic review and network meta-analysis. [PDF]

Front Pharmacol
Fu Z, Chen X, Liu H, Yang J, Jin T, Liu T, Ta G.   +6 more
europepmc   +1 more source

Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trial. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Nanayakkara N, Huang MLH, La Gerche A, Kaye DM, Cooper ME, Esler MD, Reutens AT, Shaw JE, Jenkins A, Cohen ND.   +9 more
europepmc   +1 more source

Emerging Role of Sodium-Glucose Cotransporter-2 Inhibitors in Aortic Stenosis. [PDF]

JACC Basic Transl Sci
Mazur P, Kopytek M, Natorska J.
europepmc   +1 more source

Letter to the Editor: Indication-Specific Cost-Effectiveness of Empagliflozin Versus Dapagliflozin: Implications for Clinical and Policy Decision-Making. [PDF]

Hosp Pharm
Belančić A.
europepmc   +1 more source

Empagliflozin in improving exercise tolerance in HFpEF: study protocol for an open-label, randomized controlled study. [PDF]

Trials
Huang R, Deng Y, Li M, Chen L, Lv M, Liao L, Ma L, Huang Z.   +7 more
europepmc   +1 more source

A rare case of incidental asymptomatic emphysematous cystitis in a patient taking empagliflozin. [PDF]

Urol Case Rep
Ali A, Sandoval V, Sharma N.
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights. [PDF]

Kidney360
Miyata KN, Miner JH.
europepmc   +1 more source

Early In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors After ST-Elevation Myocardial Infarction: A Clinical Review of Hemodynamic and Renal Safety. [PDF]

Rev Cardiovasc Med
Farhan M, Patel T, Almarouj D, Seyfi A, Abdi SIA, Abufanas A, Rimawi A, Al-Zuhairi I, Al-Zuhairi A, Al Azzawi A, Patel BD, Awosika A.   +11 more
europepmc   +1 more source